Kimiko Fujiwara

Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection

Yasuhiro Kidera, Hisato Kawakami, Tsutomu Sakiyama et al. · PLoS ONE · 2014 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

Macrophage inflammatory protein-1α (MIP-1α) enhances a receptor activator of nuclear factor κB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways

Masanobu Tsubaki, Chisato Kato, Miyuki Manno et al. · Molecular and Cellular Biochemistry · 2007 · 71 citations

Life Sciences, Cell Biology, Immunology +17

High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

Yasuhiro Kidera, Taroh Satoh, Shinya Ueda et al. · International Journal of Clinical Oncology · 2011 · 42 citations

Medicine, Oncology, Pharmacotherapy +17

Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib

Satomi Watanabe, Hidetoshi Hayashi, Kunio Okamoto et al. · Clinical Lung Cancer · 2016 · 41 citations

Medicine, Oncology, Pharmacology +11

A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

Koji Matsumoto, Masato Takahashi, Kazuhiko Sato et al. · Cancer Medicine · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17